newsfilter
← Latest News
Business Wire·

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2026

Overall Survival Data to be Featured at ASCO 2026 Plenary Session as Late-Breaking Abstract from HARMONi-6, a Phase III Study in 1L Squamous NSCLC in China Update Conference Call to be Held on June 1, 2026 after ASCO